Table 3.

Safety of rt‐PA at 3 months

Events	IV rt‐PA (n = 70)	Untreated (n = 66)	Odds ratio (95% CI)	P Value
Death within 7 days	15 (21.4%)	12 (18.2%)	1.23 (0.526–2.86)	0.635
Death within 3 months	24 (34.3%)	21 (31.8%)	1.12 (0.547–2.29)	0.760
ICH
Symptomatic	8 (11.4%)	3 (4.5%)	2.71 (0.687–10.7)	0.141
Total	21 (30.0%)	12 (18.2%)	1.93 (0.860–4.33)	0.108

IV, intravenous; rt‐PA, reconstructive tissue plasminogen activator; SD, standard deviation; ICH, any intracranial hemorrhage.

Data are n (%) unless otherwise indicated.